As a worldwide shortage of contrast dye for medical imaging continues, a new UC San Francisco research letter in JAMA quantified strategies medical facilities can employ to safely reduce dye use in computed tomography (CT) ...
Jun 10, 2022
0
355
Researchers from the Brigham and colleagues report on the long-term follow-up of the largest study of women's health in the U.S., shedding light on the role of menopausal hormone therapy, calcium and vitamin D supplementation, ...
May 1, 2024
0
17
Bariatric surgery is more effective than medical and lifestyle modifications for achieving long-term type 2 diabetes control and remission, according to new research led by a University of Pittsburgh School of Medicine surgeon-scientist ...
Feb 27, 2024
0
46
A Cleveland Clinic study shows that among adults with obesity, weight loss achieved with bariatric surgery was associated with a 32% lower risk of developing cancer and a 48% lower risk of cancer-related death compared with ...
Jun 3, 2022
0
439
The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of ...
Apr 6, 2024
0
122
A large multi-state study by the Centers for Disease Control and Prevention, the Harvard Pilgrim Health Care Institute, HCA Healthcare, and the University of California, Irvine has found that a nasal antibiotic ointment, ...
Oct 10, 2023
0
35
A team of medical researchers affiliated with multiple institutions in the U.S. working with a colleague from Spain has found via clinical trial that adding tirzepatide (brand name Mounjaro) to basal insulin therapies can ...
The largest ever randomized controlled trial in IgA nephropathy has found that treatment with methylprednisolone—a cheap, widely used corticosteroid drug—halves the risk of losing kidney function and kidney failure, and ...
May 17, 2022
0
11
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according ...
Feb 4, 2022
0
101
A clinical trial led by Yuejin Yang of the Chinese Academy of Medical Sciences and Peking Union Medical College, China, has concluded that a Chinese traditional medicine compound, Tongxinluo, reduced major adverse cardiac ...
